| ST. LOUIS, MO,
USA, LONDON, UK, & CAMBRIDGE, MA, USA — December 12, 2005 — Tripos, Inc. (Nasdaq:TRPS)
and InforSense today announced an alliance to integrate Tripos’ discovery
informatics portfolio with the award-winning InforSense KDE workflow-based
integrative analytics platform. Through the alliance, Tripos joins
InforSense’s Open Workflow Partner Network (OWPN) and InforSense joins
Tripos’ Alliance Program as a Software Partner. The two companies will also
integrate Tripos’ Auspyx, SYBYL and UNITY technologies with both InforSense
KDE and its ‘in Oracle’ enterprise analytics system, InforSense IOE. This
integration enables customers such as Bayer Healthcare who are using
technology from both companies, to access and integrate Tripos’ discovery
informatics technologies within InforSense KDE, thus streamlining complex
discovery processes to deliver more efficient decision-making and improved
productivity. “We are excited to work
with InforSense to benefit our joint customers,” said Bryan Koontz, senior
vice president and general manager of Discovery Informatics at Tripos. “The
integrated Tripos-InforSense solution offers a powerful and flexible
informatics platform for rapid application development and deployment, and
takes advantage of our standardization on web services and related
Service-Oriented Informatics (SOI) technologies. The technical alliance
between Tripos and InforSense is a successful example of this strategy,
providing mutual customers with even more options for deploying innovative
science and discovery software in an open workflow environment.”
“Our customers require seamless
interoperability between their choice of data resources, analytic tools and
services,” commented Joseph F. Donahue, Chief Business Officer of InforSense.
“By combining the workflow technology of InforSense KDE with Tripos’
innovative discovery informatics portfolio, we can provide our joint
customers with a flexible and easy to use environment for their chemistry
research that is able to integrate data and computing resources across the
entire R&D organization.”
About Tripos
Tripos (Nasdaq: TRPS) combines leading-edge
technology and innovative science to deliver consistently superior
chemistry-research products and services for the biotechnology,
pharmaceutical and other life science industries. Within Tripos’ Discovery
Informatics (DI) business, the company provides software products and
consulting services to develop, manage, analyze and share critical drug
discovery information. Within Tripos’ Discovery Research (DR) business,
Tripos’ medicinal chemists and research scientists partner directly with
clients in their research initiatives, leveraging state-of-the-art
information technologies and research facilities. Headquartered in St.
Louis, Mo., Tripos spans the world with global research operations and an
international client base. Further information on Tripos can be found at
www.tripos.com.
Tripos and the Tripos logo are registered
trademarks of Tripos, Inc., and/or its affiliates in the United States and
certain other countries. All other trademarks mentioned in this document are
the property of their respective owners.
This press release contains forward-looking
statements concerning expectations regarding the benefits that may be
realized by Tripos resulting from its alliance with InforSense. These
statements are based upon numerous assumptions which Tripos cannot control
and involve risks and uncertainties that could cause actual results to
differ. These statements should be understood in light of the risk factors
set forth in the Company's filings with the Securities and Exchange
Commission, including, without limitations, those factors set forth in the
Company's Form 10-K for the fiscal year ended December 31, 2004, and from
time to time in the Company's periodic filings with the Securities and
Exchange Commission. Except as otherwise required under federal securities
laws and the rules and regulations of the SEC, we do not have any intention
or obligation to update or revise any forward-looking statements, whether as
a result of new information, future events, changes in assumptions or
otherwise.
About InforSense
InforSense Limited, the leader in
integrative analytics, enables organizations to orchestrate and optimize
their business-critical decision-making processes. Leading pharmaceutical
and biotechnology, consumer goods, financial services companies, and
research institutes are using the company’s flagship product, InforSense KDE,
to enhance productivity across life science R&D, healthcare and business
analytics. The company is privately held, with European headquarters in
London, UK and North American headquarters in Cambridge, Massachusetts.
About InforSense KDE
Using InforSense KDE, enterprises rapidly
integrate and deliver virtually any data source, analytic software tool,
service or application within a single informatics framework. Users link
these components via visual workflows to dynamically answer any question
using their data, however complex or transient. Organizations can also mine
their analytical processes to discover and deploy expertise and best
practices. InforSense KDE provides an open, extensible service-oriented
architecture, built using industry standards including J2EE, XML, and WSDL.
InforSense IOE is a state-of-the-art solution for enterprise wide
integrative analytics using Oracle’s advanced information management and
processing capabilities. For further information on InforSense products and
solutions, visit
www.inforsense.com.
InforSense and the InforSense logo are
registered trademarks of InforSense Limited. All rights reserved. All other
trademarks mentioned in this document are the property of their respective
owners.
###
Contacts:
InforSense Ltd.
Judith Bandy
Director of Corporate Communications
+44 (0)207 808 9526
jbandy@inforsense.com
Tripos, Inc.
Paul Wilhite
Senior Product Marketing Manager,
Computational Informatics
(314) 951-3349
(Tripos Media only)
Waggener Edstrom Worldwide,
Bioscience and Healthcare Practice
Lisa Osborne
Account Director
(202) 326-0793
lisao@wagged.com
For more information see:
http://www.inforsense.com |
